Westport Fuel Systems Aktie - WPI

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

2,595

Gebot

2,58

Fragen

2,625

Volumen

0,00

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

2,595

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Watson Files FDA Application for Generic Nuvigil(R)

- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Jan. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global...

Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Depriva

MORRISTOWN, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced a new program encouraging health...

Watson Files FDA Application for Generic Rozerem(R)

- Paragraph IV Litigation Underway - MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading global...

Watson to Present at Credit Suisse Healthcare Conference

MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company...

Watson and Barr Settle Lawsuit Over Oxytrol(R)

CORONA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced...

Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands

MORRISTOWN, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals (NYSE:WPI), a leader in generic and specialty branded...

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

MORRISTOWN, N.J., Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today...

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, today...

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

MORRISTOWN, N.J., July 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded...

Watson CFO Mark W. Durand to Take Leave of Absence

MORRISTOWN, N.J., July 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty branded...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

WPI - Frequently Asked Questions (FAQ)

What is the current Westport Fuel Systems share price?

The current share price of Westport Fuel Systems is 2,595 €

What is the 1 year trading range for Westport Fuel Systems share price?

Westport Fuel Systems has traded in the range of 0,00 € to 0,00 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CBOImunon Inc	1,05 € (185,33%)	42,04k
4APApollo Minerals Ltd	0,011 € (57,14%)	1,69k
CNM1Carnegie Clean Energy Limited	0,0372 € (43,08%)	60,1k
N7ONLightbridge Corp	13,34 € (40,87%)	8,59k
SS6Pan American Energy Corp	0,21 € (36,36%)	200
DN3Metaplanet Inc	5,88 € (-29,83%)	6,58M
BRR2Giga Metals Corp	0,0404 € (-28,11%)	20k
CNWCodon AG	0,0145 € (-27,50%)	243
VJFVital Metals Ltd	0,0011 € (-26,67%)	500k
0XPArgo Blockchain Plc	0,0295 € (-24,74%)	47,74k
DN3Metaplanet Inc	5,88 € (-29,83%)	6,58M
D7GNel ASA	0,2178 € (1,02%)	3,73M
VSLDigital X Ltd	0,0358 € (-9,60%)	3,05M
34Q0Quantum eMotion Inc	0,542 € (10,84%)	2,58M
DMLSayona Mining Limited	0,0077 € (-16,30%)	2,12M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Westport Fuel Systems Inc (WPI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

WPI Neueste Nachrichten

Watson Files FDA Application for Generic Nuvigil(R)

Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Depriva

Watson Files FDA Application for Generic Rozerem(R)

Watson to Present at Credit Suisse Healthcare Conference

Watson and Barr Settle Lawsuit Over Oxytrol(R)

Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

Watson CFO Mark W. Durand to Take Leave of Absence

WPI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Westport Fuel Systems Inc (WPI) Börsenkurse

Westport Fuel Systems Inc (WPI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

WPI Neueste Nachrichten

Watson Files FDA Application for Generic Nuvigil(R)

Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Depriva

Watson Files FDA Application for Generic Rozerem(R)

Watson to Present at Credit Suisse Healthcare Conference

Watson and Barr Settle Lawsuit Over Oxytrol(R)

Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

Watson CFO Mark W. Durand to Take Leave of Absence

WPI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE